Prostate cancer vaccines in combination with additional treatment modalities

被引：15
|
作者：
Uhlman, Matthew A. [1 ]
Bing, Megan T. [1 ]
Lubaroff, David M. [1 ,2 ,3 ]
机构：
[1] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
来源：
IMMUNOLOGIC RESEARCH | 2014年 / 59卷 / 1-3期
关键词：
Prostate cancer; Immunotherapy; Cancer vaccines; Combination therapy; AUTOLOGOUS CELLULAR IMMUNOTHERAPY; SIPULEUCEL-T; IMMUNOSTIMULATORY PROPERTIES; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; RADIATION-THERAPY; ACID-PHOSPHATASE; DOUBLE-BLIND; PHASE-II; DOCETAXEL;
D O I：
10.1007/s12026-014-8532-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Immunotherapy has been investigated in both preclinical studies and clinical trials as a new therapy for prostate cancer. Vaccines, including those that utilize dendritic cells, viruses, or DNA, immunize against prostate-specific antigen and prostatic acid phosphatase. The vaccines have long been studied as monotherapy for the cancer, but increasingly more trials have been initiated in combination with other modalities. These include radiation, chemotherapy, and androgen deprivation therapy. This review describes and discusses the various combinations of vaccine immunotherapies.
引用
收藏
页码：236 / 242
页数：7
相关论文
共 50 条
  • [41] An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT
    Mollica, Veronica
    Marchetti, Andrea
    Rosellini, Matteo
    Nuvola, Giacomo
    Rizzo, Alessandro
    Santoni, Matteo
    Cimadamore, Alessia
    Montironi, Rodolfo
    Massari, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [42] Tissue vaccines for prevention and treatment of prostate cancer
    Suckow, M. A.
    Hall, P.
    Hiles, M. C.
    2ND GLOBAL CONGRESS ON VACCINES, 2009, 1 (01): : 124 - 126
  • [43] A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
    Sooi, Kenneth
    Walsh, Robert
    Kumarakulasinghe, Nesaretnam
    Wong, Alvin
    Ngoi, Natalie
    CANCER DRUG RESISTANCE, 2023, 6 (03) : 656 - 673
  • [44] Combination immunotherapy: Taking Cancer vaccines to the next Level
    Grenier, Jeremy M.
    Yeung, Stephen T.
    Khanna, Kamal M.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [45] Radiation and Anti-Cancer Vaccines: A Winning Combination
    Cadena, Alexandra
    Cushman, Taylor R.
    Anderson, Clark
    Barsoumian, Hampartsoum B.
    Welsh, JamesW.
    Cortez, Maria Angelica
    VACCINES, 2018, 6 (01):
  • [46] Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
    Liao, Juan-Yan
    Zhang, Shuang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines
    Bartzatt, Ronald
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (10) : 847 - 854
  • [48] Clinical-Prostate cancer Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities
    Muise, Alexandra
    Pan, Michael M.
    Rose, Brent
    Buckley, Jill C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 104.e1 - 104.e9
  • [49] Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects
    Kothari, Nirjari
    Postwala, Humzah
    Pandya, Aanshi
    Shah, Aayushi
    Shah, Yesha
    Chorawala, Mehul R.
    MEDICAL ONCOLOGY, 2023, 40 (05)
  • [50] Vaccines for the treatment of non-small cell lung cancer
    Leduc, C.
    Quoix, E.
    REVUE DES MALADIES RESPIRATOIRES, 2019, 36 (03) : 415 - 425
12345